STEPHANIE HANSMAN: Open Payments
NPI 1497491062 · FRANKLIN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 15 payments from 11 companies in 2025. Trend: 2023 $465 · 2024 $449 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $55 |
| Lilly USA, LLC | 2 | $43 |
| Lundbeck LLC | 1 | $33 |
| HARMONY BIOSCIENCES LLC | 1 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| Amgen Inc. | 1 | $17 |
| Exact Sciences Corporation | 1 | $17 |
Products named: MOUNJARO, Ozempic, REXULTI, WAKIX, Auvelity, TRELEGY ELLIPTA, Wegovy, PREVNAR 20.
Industry payments across IN — which companies pay providers there.
